Puca, Loredana <br/><br/>
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.  [electronic resource] 

 -  Science translational medicine  03 2019 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aav0891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Benzodiazepinones--pharmacology<br/>Carcinoma, Neuroendocrine--drug therapy<br/>Cell Line, Tumor<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genetic Heterogeneity<br/>Humans<br/>Immunoconjugates--pharmacology<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Male<br/>Membrane Proteins--genetics<br/>Mice<br/>Molecular Targeted Therapy<br/>Neoplastic Cells, Circulating--metabolism<br/>Prostatic Neoplasms--drug therapy<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Time Factors<br/>Treatment Outcome